Sarepta FDA Request - Search News

Order byBest matchMost fresh

News

FDA Will Ask Sarepta to Halt Gene Therapy Shipments

Sarepta under pressure: FDA requests halt of Elevidys shipments

Sarepta Therapeutics (SRPT) stock is in focus after the US Food and Drug Administration (FDA) asked the company to halt shipments of Elevidys, a treatment that has been linked to multiple patient deaths.

Continue reading

BioPharma Dive · 1h

FDA asks Sarepta to stop shipping Duchenne gene therapy

· 2d · on MSN

Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

MedPage Today4h

Drugmaker Refuses FDA's Request to Pull Gene Therapy Tied to Patient Deaths

The agency also revoked Sarepta's platform technology designation for AAVrh74 Friday and issued a safety communication saying ...

5h

Sarepta Therapeutics stock sinks after FDA tells company to stop shipping its bestselling drug

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

12hon MSN

Sarepta stock extends decline as company declines FDA call to withdraw drug

Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results